Cargando…
Reversible severe fatty liver induced by capecitabine: A case report
RATIONALE: Capecitabine (CAP) is a chemotherapeutic agent used to treat breast and gastrointestinal cancers. The most common adverse reactions of CAP primarily included gastrointestinal and dermatological effects. Whereas, the CAP-induced fatty liver had never been reported. PATIENT CONCERNS: In thi...
Autores principales: | Jiang, Yiyan, He, Qiancheng, Li, Suxia, Shi, Chang, Yang, Xiaolei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704805/ https://www.ncbi.nlm.nih.gov/pubmed/29145260 http://dx.doi.org/10.1097/MD.0000000000008547 |
Ejemplares similares
-
Severe polycystic liver diseases: hepatectomy or waiting for liver transplantation?: Two case reports
por: Zhang, Zeyu, et al.
Publicado: (2019) -
Methimazole-induced liver injury overshadowed by methylprednisolone pulse therapy: Case report
por: Abramavicius, Silvijus, et al.
Publicado: (2017) -
Polymyxin B-induced rhabdomyolysis: A case report
por: Ni, Ming, et al.
Publicado: (2020) -
CYP1A2 polymorphism may contribute to agomelatine-induced acute liver injury: Case report and review of the literature
por: Wang, Shushan, et al.
Publicado: (2021) -
Case report: severe myoclonus associated with oral midodrine treatment for hypotension
por: Ye, Xiaolan, et al.
Publicado: (2020)